1. Link between gut microbiota and health outcomes in inulin -treated obese patients:Lessons from the Food4Gut multicenter randomized placebo-controlled trial
- Author
-
Gaetan Kalala, Giorgia Zamariola, Jean-Paul Thissen, Nicolas Lanthier, Pierre Trefois, Daphnée Portheault, Laure B. Bindels, Miriam Cnop, Marco Gianfrancesco, Olivier Klein, Julie Rodriguez, Olivier Luminet, Audrey Loumaye, Quentin Leyrolle, Carolina Gomes da Silveira Cauduro, Nathalie M. Delzenne, Anne-Sophie Azzi, Barbara D. Pachikian, Maria D.G.H. Mulders, Nicolas Paquot, Camille Amadieu, Audrey M. Neyrinck, Patrice D. Cani, Sophie Hiel, Jérôme Bindelle, UCL - SSH/IPSY - Psychological Sciences Research Institute, UCL - SSS/IONS - Institute of NeuroScience, UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - SSS/IONS/CEMO - Pôle Cellulaire et moléculaire, UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - SSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition, UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, UCL - (SLuc) Service de radiologie, UCL - (SLuc) Service de gastro-entérologie, and UCL - (SLuc) Service d'endocrinologie et de nutrition
- Subjects
0301 basic medicine ,Male ,medicine.medical_treatment ,Placebo-controlled study ,Blood Pressure ,Gut flora ,Critical Care and Intensive Care Medicine ,Gastroenterology ,Body Mass Index ,chemistry.chemical_compound ,Feces ,0302 clinical medicine ,Weight loss ,Vegetables ,Medicine ,Single-Blind Method ,Nutrition and Dietetics ,biology ,Anthropometry ,Microbiota ,Inulin ,Middle Aged ,Metformin ,Treatment Outcome ,Female ,medicine.symptom ,medicine.drug ,Adult ,medicine.medical_specialty ,Adolescent ,030209 endocrinology & metabolism ,Placebo ,03 medical and health sciences ,Young Adult ,Polysaccharides ,Internal medicine ,Weight Loss ,Humans ,Microbiome ,Obesity ,Nutrition ,Aged ,Caloric Restriction ,030109 nutrition & dietetics ,business.industry ,Prebiotic ,Feeding Behavior ,biology.organism_classification ,Gastrointestinal Microbiome ,Prebiotics ,chemistry ,business ,Energy Intake - Abstract
Background: The gut microbiota is altered in obesity and is strongly influenced by nutrients and xenobiotics. We have tested the impact of native inulin as prebiotic present in vegetables and added as a supplement on gut microbiota-related outcomes in obese patients. Metformin treatment was analyzed as a potential modulator of the response. Methods: A randomized, single-blinded, multicentric, placebo-controlled trial was conducted in 150 obese patients who received 16 g/d native inulin versus maltodextrin, coupled to dietary advice to consume inulin-rich versus -poor vegetables for 3 months, respectively, in addition to dietary caloric restriction. Anthropometry, diagnostic imaging (abdominal CT-scan, fibroscan), food-behavior questionnaires, serum biology and fecal microbiome (primary outcome; 16S rDNA sequencing) were analyzed before and after the intervention. Results: Both placebo and prebiotic interventions lowered energy intake, BMI, systolic blood pressure, and serum γ-GT. The prebiotic induced greater weight loss and additionally decreased diastolic blood pressure, AST and insulinemia. Metformin treatment compromised most of the gut microbiota changes and metabolic improvements linked to prebiotic intervention. The prebiotic modulated specific bacteria, associated with the improvement of anthropometry (i.e. a decrease in Desulfovibrio and Clostridium sensu stricto). A large increase in Bifidobacterium appears as a signature of inulin intake rather than a driver of prebiotic-linked biological outcomes. Conclusions: Inulin-enriched diet is able to promote weight loss in obese patients, the treatment efficiency being related to gut microbiota characteristics. This treatment is more efficacious in patients who did not receive metformin as anti-diabetic drugs prior the intervention, supporting that both drug treatment and microbiota might be taken into account in personalized nutrition interventions. Registered under ClinicalTrials.gov Identifier no NCT03852069., info:eu-repo/semantics/published
- Published
- 2020
- Full Text
- View/download PDF